文献速递主动脉疾病

降胸主动脉退行性囊状与梭形动脉瘤的临床表现、结局及按性别划分的修复阈值

Clinical presentation, outcomes, and threshold for repair by sex in degenerative saccular vs fusiform aneurysms in the descending thoracic aorta.
PubMed 文献 · J Vasc Surg · 2023-08-30

基于VQI数据库2012至2022年因降胸主动脉退行性动脉瘤行TEVAR的患者,比较囊状与梭形动脉瘤的临床表现、治疗及结局。囊状动脉瘤在女性和男性中分别更常在低于修复阈值(女性<50mm、男性<55mm)时行急诊/紧急TEVAR,相对风险分别为3.39和2.26。择期囊状动脉瘤患者5年死亡率高于梭形(23% vs 17%,HR 1.53)。

要点

  • 囊状降胸主动脉瘤较梭形更常在低于阈值时行急诊/紧急TEVAR(女性<50mm RR 3.39,男性<55mm RR 2.26)。
  • 择期TEVAR后囊状动脉瘤5年死亡率高于梭形(23% vs 17%,HR 1.53)。
  • 择期囊状动脉瘤术后脊髓缺血率低于梭形(0.7% vs 3.2%,P=.010)。

核心结论

  • 囊状降胸主动脉瘤在较小直径即行急诊/紧急TEVAR,支持现行指南关于囊状动脉瘤应在较小直径治疗的推荐。
  • 数据支持对梭形动脉瘤采用性别特异性治疗阈值,但不支持对囊状动脉瘤采用性别特异性阈值。
  • 急诊/紧急队列中两种形态TEVAR术后结局无差异,但择期治疗的囊状动脉瘤患者5年死亡率高于梭形动脉瘤患者。

研究设计与样本

  • 回顾性分析血管质量倡议(VQI)数据库2012年至2022年因降胸主动脉退行性动脉瘤行TEVAR的所有患者。
  • 按紧急程度分层:急诊/紧急(破裂/症状性)与择期修复,比较梭形与囊状动脉瘤的人口学、合并症、解剖/手术特征及结局。
  • 采用累积分布曲线按性别分层绘制不同主动脉直径下行急诊/紧急修复的患者比例。

主要发现

  • 655例急诊/紧急TEVAR中37%为囊状动脉瘤,1352例择期TEVAR中35%为囊状形态。
  • 女性囊状vs梭形在<50mm行急诊/紧急TEVAR比例为38% vs 10%(相对风险3.39,95%CI 2.04-5.70,P<.001)。
  • 男性囊状vs梭形在<55mm行急诊/紧急TEVAR比例为47% vs 21%(相对风险2.26,95%CI 1.60-3.18,P<.001)。
  • 急诊/紧急梭形动脉瘤中女性就诊直径小于男性,而囊状动脉瘤患者术前动脉瘤直径无差异。
  • 择期囊状vs梭形术后脊髓缺血率为0.7% vs 3.2%(P=.010),5年死亡率为23% vs 17%(风险比1.53,95%CI 1.12-2.10,P=.010)。

关键数值与推荐

  • 女性囊状vs梭形在<50mm行急诊/紧急TEVAR:38% vs 10%(相对风险3.39,95%CI 2.04-5.70,P<.001)。
  • 男性囊状vs梭形在<55mm行急诊/紧急TEVAR:47% vs 21%(相对风险2.26,95%CI 1.60-3.18,P<.001)。
  • 择期囊状vs梭形术后脊髓缺血:0.7% vs 3.2%(P=.010)。
  • 择期囊状vs梭形5年死亡率:23% vs 17%(风险比1.53,95%CI 1.12-2.10,P=.010)。

临床怎么用

  • 作者认为数据支持现行临床实践指南关于囊状降胸主动脉瘤应在较小直径治疗的推荐。
  • 作者认为数据支持对梭形动脉瘤患者采用性别特异性治疗阈值,但不支持对囊状动脉瘤患者采用性别特异性阈值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Saccular-shaped thoracic aortic aneurysms (TAAs) are often treated at smaller diameters compared with fusiform TAAs, despite a lack of strong clinical evidence to support this practice. The aim of this study was to examine differences in presentation, treatment, and outcomes between saccular TAAs and fusiform TAAs in the descending thoracic aorta. We also examined the need for sex-specific treatment thresholds for TAAs. METHODS: All Vascular Quality Initiative (VQI) patients undergoing thoracic endovascular aneurysm repair (TEVAR) for degenerative TAAs in the descending thoracic aorta from 2012 through 2022 were reviewed. Patients were stratified by urgency: emergent/urgent vs elective repairs (ruptured/symptomatic). Demographics, comorbidities, anatomical/procedural characteristics, and outcomes for fusiform TAAs and saccular TAAs were compared. Cumulative distribution curves were used to plot the proportion of patients who underwent emergent/urgent repair according to sex-stratified aortic diameter. RESULTS: Among 655 emergent/urgent TEVARs, 37% were performed for saccular TAAs, whereas among 1352 elective TEVARs, 35% had saccular TAA morphology. Compared with fusiform TAAs, saccular TAAs more frequently underwent emergent/urgent (ruptured/symptomatic) TEVAR below the repair threshold in both females (<50 mm: 38% vs 10%; relative risk, 3.39; 95% confidence interval [CI], 2.04-5.70; P < .001), and males (<55 mm: 47% vs 21%; relative risk, 2.26; 95% CI, 1.60-3.18; P < .001). Moreover, among patients with emergent/urgent fusiform TAAs, females presented at smaller diameters compared with males, whereas there was no difference in preoperative aneurysm diameter among patients with saccular TAAs. Regarding outcomes, emergent/urgent treated saccular TAAs had similar postoperative outcomes and 5-year mortality compared with fusiform TAAs. Nevertheless, in the elective cohort, patients with saccular TAAs had similar postoperative mortality compared with those with fusiform TAAs, but a lower rate of postoperative spinal cord ischemia (0.7% vs 3.2%; P = .010). Furthermore, patients with saccular TAAs had a higher rate of 5-year mortality compared with their fusiform counterparts (23% vs 17%; hazard ratio, 1.53; 95% CI, 1.12-2.10; P = .010). CONCLUSIONS: Patients with saccular TAAs underwent emergent/urgent TEVAR at smaller diameters than those with fusiform TAAs, supporting current clinical practice guideline recommendations that saccular TAAs warrant treatment at smaller diameters. Furthermore, these data support a sex-specific treatment threshold for patients with fusiform TAAs, but not for those with saccular TAAs. Although there were no differences in outcomes following TEVAR between morphologies in the emergent/urgent cohort, patients with saccular TAAs who were treated electively were associated with higher 5-year mortality compared with those with fusiform TAAs.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rastogi V, Guetter CR, Patel PB, et al. Clinical presentation, outcomes, and threshold for repair by sex in degenerative saccular vs fusiform aneurysms in the descending thoracic aorta. J Vasc Surg. 2023. PMID: 37652142. doi:10.1016/j.jvs.2023.06.104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。